Clearside Biomedical, Inc. and Santen, Inc. Announce Research Collaboration...
Clearside Biomedical, Inc. and Santen, Inc. Announce Research Collaboration in Glaucoma Expands Previous Research Collaboration to Include 2nd Largest Ophthalmic Market Alpharetta, GA and Emeryville,...
View ArticleSpyryx Biosciences Secures $18 Million in Series A Financing
Spyryx Biosciences Secures $18 Million in Series A Financing • Funding to Develop Novel Therapeutics for Respiratory Diseases • Venture Syndicate has Strong Respiratory Expertise Research Triangle...
View ArticleNuSirt Biopharma Raises $6 Million in Series C Funding
NuSirt Biopharma Raises $6 Million in Series C Funding Financing led by Hatteras Venture Partners accelerates Type 2 diabetes program Company launches new clinical program in non-alcoholic fatty liver...
View ArticleORIG3N™ Announces Strategic Collaboration with LabCorp
ORIG3N™ Announces Strategic Collaboration with LabCorp LabCorp will provide industry-leading scientific resources in personalized diagnostics and genomic testing to support the capacity of ORIG3N’s...
View ArticleWildflower Health secures $5 million in financing to expand mobile,...
SAN FRANCISCO, June 25, 2015 — Wildflower Health, maker of mobile maternity program Due Date Plus (www.wildflowerhealth.com/programs), today announced a $5 million investment in the company to...
View ArticleAerie Pharmaceuticals and GrayBug Announce Research Collaboration Focused on...
IRVINE, California & BALTIMORE, Maryland – (BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and...
View ArticleG1 Therapeutics Announces Initiation of Two Phase 1b/2a Trials of CDK4/6...
Trials will assess G1T28 as a bone marrow and immune system chemoprotectant in newly diagnosed and previously treated patients with small-cell lung cancer G1T28 was well-tolerated and demonstrated...
View ArticleHatteras Venture Partners Announces First Closing of HVP V
– HVP V to build on success of Hatteras Discovery to further enhance early stage pipeline creation – Malin Corporation PLC and the University of North Carolina at Chapel Hill join existing limited...
View ArticlePatient engagement platform Medfusion reels in $3 million
Cary, North Carolina-based patient engagement platform Medfusion Inc has raised $3 million in funding. The investors were Bull City Venture Partners and Hatteras Venture Partners. In conjunction with...
View ArticleStartup Qvella gets $20M Series A to develop rapid pathogen detection test
It’s been more than a decade in the making, but Qvella is close to the holy grail of diagnostics–a compact, inexpensive pathogen analyzer that identifies the precise culprit in only 30 minutes. The...
View ArticleClik here to view.
5 Mission-Driven Companies That Are Changing The World
When I was a senior in college, my career goals were fairly simple. I wanted to work for a company that was doing something I cared deeply about. So, when I started actually looking for jobs, I limited...
View ArticleClik here to view.
Clearside Biomedical, Inc. Completes $20 Million Series C Financing
December 03, 2015 07:30 AM Eastern Standard Time ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing innovative first-in-class drug...
View ArticleORIG3N™ Closes $12.5 Million in Funding Lead by Hatteras Venture Partners and...
Funding will support accelerated growth of LifeCapsule™ and the 2016 launch of LifeSystems™ offering to develop safer and more effective drugs. BOSTON, Dec. 16, 2015 /PRNewswire/ — ORIG3N Inc., a...
View ArticleClearside Biomedical, Inc. Announces Positive Topline Data from Phase 2...
Clinical Trial Achieves Statistical Significance on Primary Efficacy Endpoint January 05, 2016 07:30 AM Eastern Standard Time ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, Inc., a late-stage...
View ArticleImproving Odds for Women in Tech? Take Notes from Biotech
Joan Siefert Rose Xconomy Boston — At our entrepreneurial support organization, the Council for Entrepreneurial Development (CED), we often joke about adhering to the proper dress and catering code for...
View ArticleMedfusion Announces Latest Version of Medfusion Plus at HIMSS16
Leading Mobile App Aggregates Health Data into One Place to Help Put Patients in Control of their Health and Care March 01, 2016 09:00 AM Eastern Standard Time CARY, N.C.–(BUSINESS WIRE)–Medfusion, a...
View ArticleCarolina Research Ventures Selects Hatteras as Manager of Investments
– Investments to be focused on rich pipeline of assets and companies emerging from UNC-Chapel Hill – Selection of Hatteras builds on track record of investments in the UNC ecosystem March 2, 2016 –...
View ArticleClik here to view.
TBJ names 2016 Women in Business Lifetime Achievement Award winner
Feb 29, 2016, 2:33pm EST Each year as a part of its annual Women In Business Awards, Triangle Business Journal selects a female executive who has impacted the Triangle community not only with the work...
View ArticleBivarus Raises $2 Million to Fuel Expansion Following Strong Growth in 2015
Investors from RTP, Nashville and Boston Participate DURHAM, N.C. (Business Wire) March 23, 2016 – Bivarus, a patient-centered analytics company working with healthcare organizations to measure and...
View ArticleHatteras Venture Partners Earns CEO Cancer Gold Standard Accreditation
CARY, N.C.–(BUSINESS WIRE)–The CEO Roundtable on Cancer has accredited Hatteras Venture Partners, an early-stage venture capital investment company in Durham, N.C., with the CEO Cancer Gold StandardTM...
View Article
